1800-272-662
Shopping Cart 0
countryflagAU
Login

Inoviq Ltd

Healthcare AU IIQ

0.33AUD
0.005(1.54%)

Last update at 2026-03-13T05:10:00Z

Day Range

0.320.34
LowHigh

52 Week Range

0.320.69
LowHigh

Fundamentals

  • Previous Close 0.33
  • Market Cap46.46M
  • Volume135527
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-6.38802M
  • Revenue TTM2.10M
  • Revenue Per Share TTM0.02
  • Gross Profit TTM -2.08430M
  • Diluted EPS TTM-0.06

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -6.93228M -6.55400M -10.06412M -8.57336M -14.00587M
Minority interest - - - - -
Net income -6.93228M -6.55400M -8.96924M -6.51485M -12.36712M
Selling general administrative 5.31M 3.21M 3.40M 2.22M 4.08M
Selling and marketing expenses 0.47M 0.43M 0.77M 0.55M 0.24M
Gross profit -1.55963M 0.45M -1.04002M 0.22M 0.40M
Reconciled depreciation - 1.20M 1.15M 1.96M 0.89M
Ebit -7.34402M -7.54003M -10.41645M -8.07894M 0.28M
Ebitda -6.15749M -6.33603M -9.02272M -6.18496M 1.17M
Depreciation and amortization 1.19M 1.20M 1.39M 1.89M 0.89M
Non operating income net other - - - - -
Operating income -10.59858M -7.79661M -10.41645M -8.07894M 0.28M
Other operating expenses 12.41M 8.37M 10.81M 9.50M 7.51M
Interest expense 0.02M 0.04M 0.06M 0.08M 0.10M
Tax provision 0.00000M 0.00000M 0.00000M -2.05851M -2.87481M
Interest income - 0.26M 0.35M 0.07M 0.04M
Net interest income - 0.26M 0.35M -0.01630M -0.05632M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -1.02644M -1.09488M -2.05851M -1.63875M
Total revenue 1.82M 0.54M 0.40M 0.28M 0.47M
Total operating expenses 9.04M 8.29M 9.38M 9.44M 7.44M
Cost of revenue 3.37M 0.08M 1.44M 0.06M 0.06M
Total other income expense net 3.67M 1.28M 0.35M 0.58M -6.90934M
Discontinued operations - - - - -
Net income from continuing ops - -6.55435M -8.96924M -18.19598M -12.36712M
Net income applicable to common shares -6.93228M -6.55435M -8.96924M -18.19598M -11.15088M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 18.46M 21.71M 21.51M 30.78M 33.52M
Intangible assets 8.68M - 10.65M 12.32M 25.56M
Earning assets - - - - -
Other current assets 1.97M 0.33M - 0.35M 0.38M
Total liab 1.74M 1.72M 1.89M 2.49M 4.46M
Total stockholder equity 16.71M 19.99M 19.62M 28.29M 29.06M
Deferred long term liab - - - - -
Other current liab 0.97M 0.54M - 0.42M 0.51M
Common stock 78.05M 75.13M 69.05M 69.05M 51.83M
Capital stock - - 69.05M 69.05M 51.83M
Retained earnings -62.99897M -56.91562M -51.07252M -30.17640M -25.17096M
Other liab - - 0.00715M 0.05M 2.09M
Good will - - 0.00000M 11.03M 11.03M
Other assets - 0.00000M - - -
Cash 6.52M 9.23M 7.81M 15.39M 5.00M
Cash and equivalents - - 7.81M 15.39M 5.00M
Total current liabilities 1.51M 1.53M 1.52M 1.80M 1.46M
Current deferred revenue - - - - -
Net debt -6.14473M -8.69813M - -14.39616M -3.73443M
Short term debt 0.20M 0.37M 0.00000M 0.36M 0.35M
Short long term debt - - - - -
Short long term debt total 0.38M 0.54M - 1.00M 1.26M
Other stockholder equity - - 1.63M -11.68113M 1.22M
Property plant equipment - - 1.45M 1.65M 1.73M
Total current assets 8.70M 10.86M 9.40M 17.47M 5.65M
Long term investments - - - - -
Net tangible assets - - 8.96M 16.63M 2.91M
Short term investments - - - - -
Net receivables 0.16M 1.27M 1.19M 1.71M 0.22M
Long term debt - - - - -
Inventory 0.05M 0.02M 0.02M 0.01M 0.05M
Accounts payable 0.35M 0.63M 0.47M 1.02M 0.60M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1.66M 1.78M - 1.10M 1.18M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 9.70M - -11.68113M 0.58M
Deferred long term asset charges - - - - -
Non current assets total 9.75M 10.85M 12.11M 13.31M 27.87M
Capital lease obligations - - 0.73M 1.00M 1.26M
Long term debt total - - 0.37M 0.64M 0.92M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - -0.17434M -0.29227M -0.41190M 2.98M
Change to liabilities - - -0.20933M 0.28M -0.03671M
Total cashflows from investing activities -0.10400M -0.17434M -0.29227M -0.41190M 2.64M
Net borrowings - - -0.26798M -0.26545M -0.33566M
Total cash from financing activities 2.05M 5.91M -0.26798M 16.87M 0.29M
Change to operating activities - - -0.08614M 0.09M -0.07698M
Net income -6.93228M -6.55435M -8.96924M -18.19598M -11.15088M
Change in cash -2.71227M 1.42M -7.58234M 10.40M -2.32830M
Begin period cash flow 9.23M 7.81M 15.39M 5.00M 7.33M
End period cash flow 6.52M 9.23M 7.81M 15.39M 5.00M
Total cash from operating activities -4.66267M -4.32292M -7.02457M -6.06116M -5.26038M
Issuance of capital stock - 6.75M - 18.46M 0.29M
Depreciation 1.38M 1.44M 1.39M 2.10M 0.91M
Other cashflows from investing activities - -0.01350M -0.01808M -0.12608M -0.33566M
Dividends paid - - - 0.27M -
Change to inventory -0.02896M -0.00002M -0.00439M 0.03M -0.04750M
Change to account receivables -0.39850M 0.02M 0.46M -1.48629M -0.19819M
Sale purchase of stock 2.63M -0.50853M 0.00000M -1.24035M 0.29M
Other cashflows from financing activities -0.32790M -0.32698M -0.26798M -0.08196M 0.34M
Change to netincome - - 0.39M 11.03M 5.34M
Capital expenditures 0.10M 0.17M 0.29M 0.41M 0.79M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.25169M 0.09M 0.16M -1.07636M -0.35939M
Stock based compensation 0.82M 0.83M 0.33M 0.30M 0.69M
Other non cash items 0.32M -0.13826M 2.94M 16.48M 7.44M
Free cash flow -4.76667M -4.49726M -7.31684M -6.47306M -6.04621M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
IIQ
Inoviq Ltd		 0.005 1.54% 0.33 - - 22.10 2.06 56.55 -3.2264
SHL
Sonic Healthcare Ltd		 0.09 0.43% 21.20 19.10 15.48 1.01 1.22 1.52 8.99
IDX
Integral Diagnostics Ltd		 0.01 0.43% 2.32 57.75 15.80 1.12 1.30 1.89 12.08
HLS
Healius Ltd		 - -% 0.59 - 26.25 0.32 0.78 0.96 10.14
ACL
Australian Clinical Labs Ltd		 -0.02 0.97% 2.05 14.79 12.17 0.54 2.75 0.96 3.92

Reports Covered

Stock Research & News

View All

Profile

INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development. It offers non-invasive, diagnostics using its proprietary exosome develops technologies for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was founded in 2016 and is headquartered in Notting Hill, Australia.

Inoviq Ltd

23 Normanby Road, Notting Hill, VIC, Australia, 3168

Key Executives

Name Title Year Born
Dr. Leearne Maree Hinch B.Sc., B.V.M.S., BSc., M.B.A., M.R.C.V.S. Chief Exec. Officer NA
Prof. Gregory Edward Rice BSc (Hons), GradDipMgt, MHA, Ph.D. Chief Scientific Officer NA
Mr. Mark Edwards BAcc, C.A., CA CFO & Company Sec. NA
Dr. Leearne Maree Hinch B.Sc., B.V.M.S., BSc., M.B.A., M.R.C.V.S. Chief Executive Officer NA
Mr. Mark Edwards BAcc, C.A., CA CFO & Company Secretary NA
Dr. Leearne Maree Hinch B.Sc., B.V.M.S., BSc., M.B.A., M.R.C.V.S. Chief Executive Officer NA
Mr. Mark Edwards BAcc, C.A., CA CFO & Company Secretary NA
Dr. Leearne Maree Hinch B.Sc., B.V.M.S., BSc., M.B.A., M.R.C.V.S. Chief Executive Officer NA
Mr. Mark Edwards BAcc, C.A., CA CFO & Company Secretary NA
Dr. Leearne Maree Hinch B.Sc., B.V.M.S., BSc., M.B.A., M.R.C.V.S. Chief Executive Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.